Clinical Trials for Biosight

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Biosight

Clinical Trials (1)

NCT05503355
A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML
PHASE1/PHASE2Recruiting
80 participants
Started: Aug 17, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor3 locations